Publications - Centre d'Investigations Cliniques

PublicationsMarcGuevreguian2022-12-30T09:28:32+01:00

PUBLICATIONS

2021	2022

Un exemple de réorganisation dans le fonctionnement d’un CIC en période de confinement national suite à la pandémie COVID-19

The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting Therapies

Transient expansion of TP53 mutated clones in polycythemia vera patients treated with idasanutlin

Determining the recommended dose of pacritinib

From leeches to interferon: should cytoreduction be prescribed for all patients with polycythemia vera?

Selective Oral MEK1/2 Inhibitor Pimasertib

The Final Analysis of Expand

Correlation Analyses of Imetelstat Exposure with PharmacodynamicE ect, E icacy and Safety…

Splenectomy before allogeneic hematopoietic cell transplantation for myelofibrosis: A French nationwide study

Benefits of molecular profiling with next-generation sequencing…

A Multicenter Phase II Study of Pazopanib in Patients with Unresectable Dermatofibrosarcoma Protuberans

Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups

Molecular profiling and risk classification of patients…

Spliceosome mutations are common in persons with myeloproliferative neoplasm…

Long-term efficacy and safety of ruxolitinib in polycythaemia vera – Authors’ reply

Long-term follow-up of JAK2 exon 12 polycythemia vera

A Phase Ib/II Study of the BRAF Inhibitor Encorafenib…

Risk factors for vascular liver diseases Vascular liver diseases